THOMPSON DAVIS & CO., INC. - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 42 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 7.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2014$7,0006,0000.01%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2014.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders